Learn if You Have a Claim Against Ethicon Inc. (Maker of GYNECARE INTERGEL)

Surgical Solution GYNECARE INTERGEL Linked to Serious Side Effects Kahn Gauthier Swick is investigating possible legal actions against Ethicon Inc. on behalf of women who were harmed by the use of GYNECARE INTERGEL Adhesion Prevention Solution in the course of gynecological or other surgery.
Claimant Information

Are you submitting this information on behalf of yourself?	Yes No
Are you submitting this information on behalf of a family member?	Yes No
If yes, please provide: Name
Age
Relationship
Medical Information

Was your surgery after November 16, 2001?	Yes No
Please describe any damages sustained as a result of an adhesion prevention solution (a thick liquid gel).
Are you presently covered by health insurance?	Yes No
Have you previously retained an attorney to represent you in this matter?	Yes No

Personal Information

First Name

Last Name

Street / Apt /

City, State Zip

Home Phone & Evening Phone (Same) . . & . .

E-Mail Address

Confirm E-Mail

Date Issue/Problem

Terms & Conditions
I acknowledge that I have read and understand and agree to the following legal policies.

Certain features of Lawcash.com require a login - please simply choose a password to continue.

Password

Confirm Password

I'd like to become a Lawcash.com member, receive a free class action ebook, and free class action and recall alerts. Billions of dollars are available each year and I'd like to claim my fair share from bad corporations.

Submit

Other Drugs / Medical Cases of Interest

Arkansas Teacher Retirement System Claims Drug Testing Company Violated Procedures in Clinical Trials

The Arkansas Teacher Retirement System filed a class action lawsuit against SFBC International, a drug testing company accused of violating regulatory procedures in administering clinical trials.

Women Sue Maker of Birth Control Patch

Ten women filed a lawsuit against Johnson & Johnson and its subsidiary Ortho McNeil on July 25, 2005, claiming the birth control device the company manufactures caused them to suffer strokes and blood clots.

Dr. Phil McGraw’s Shape Up! Products Under Fire for False Advertising

A class action has been filed against TV self-help authority Dr. Phil McGraw and nutritional supplement manufacturer CSA Nutraceuticals on behalf of all persons who have purchased Shape Up! weight-loss products. The action alleges that the products are being advertised in a deceptive and untruthful manner, in violation of California consumer protection laws, and seeks unspecified compensatory and punitive damages.

Rapid City Regional Hospital Accused of Not Providing Charitable Care

A class action has been filed against Rapid City Regional Hospital, a hospital located in Rapid City, South Dakota for not providing charitable care to uninsured patients as required under their tax-exempt status. The class action has also been filed against the American Hospital Association, the national organization that represents and serves hospitals, health care networks, and their patients and communities for misleading the hospital on matters of charitable care.

OSI Pharmaceuticals Seek $360M in Lost Stock Value

A class action has been filed in the Eastern District Court of New York against OSI Pharmaceuticals, Inc.(NASDAQ: OSIP), a New York based biopharmaceutical company, and certain of its officers and directors by stockholders who purchased the company's common stock between April, 26 2004 and November 18, 2004. The action claims that the defendants violated federal securities laws by issuing a series of material misrepresentations to the market over this time period, thereby artificially inflating the price of the company's securities. The stockholders seek to recover compensatory damages for the loss of value of their stock.

Shareholder Lawsuit Filed Against D&K Healthcare Resources

Several class actions have been filed against pharmaceuticals and healthcare supply wholesaler D&K Healthcare Resources, Inc. (Nasdaq:DKHR) and certain of its officers and directors by stockholders who purchased the company's common stock between April 23, 2001, and September 16, 2002. The actions claim that the defendants violated federal securities laws by issuing a series of material misrepresentations to the market over this time period, thereby artificially inflating the price of the company's securities.